Fakhrai; Habib

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fakhrai; Habib.The latest application filed is for "immune stimulation/metabolic inhibition as antitumor therapy".

Company Profile

0.4.11

Fakhrai; Habib - La Jolla CA
Fakhrai; Habib - Oceanside CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immune Stimulation/metabolic Inhibition As Antitumor Therapy App 20150037357 - Fakhrai; Habib ; et al.	2015-02-05
Predictors Of Response To Immunotherapy App 20140248297 - Fakhrai; Habib ; et al.	2014-09-04
Compositions For Treatment Of Cancer App 20140194478 - KARIMI-BUSHERI; Feridoun ; et al.	2014-07-10
Compositions For Treatment Of Cancer App 20140194429 - KARIMI-BUSHERI; Feridoun ; et al.	2014-07-10
Compositions For Treatment Of Cancer App 20140194465 - KARIMI-BUSHERI; Feridoun ; et al.	2014-07-10
Compositions For Treatment Of Cancer App 20140194507 - KARIMI-BUSHERI; Feridoun ; et al.	2014-07-10
Compositions For Treatment Of Cancer App 20140194463 - KARIMI-BUSHERI; Feridoun ; et al.	2014-07-10
Universal Tumor Cell Vaccine For Anti Cancer Therapeutic And Prophylactic Utilization App 20130064856 - FAKHRAI; Habib ; et al.	2013-03-14
Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization Grant 8,293,252 - Fakhrai , et al. October 23, 2	2012-10-23
Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells Grant 7,740,837 - Fakhrai June 22, 2	2010-06-22
Universal Tumor Cell Vaccine For Anti Cancer Therapeutic And Prophylactic Utilization App 20100047289 - Fakhrai; Habib ; et al.	2010-02-25
Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells App 20070264242 - Fakhrai; Habib	2007-11-15
Genetically modified cells expressing a TGF.beta. inhibitor, the cells being lung cancer cells Grant 7,101,543 - Fakhrai September 5, 2	2006-09-05
Genetically modified cells expressing a TGFbeta inhibitor, the cells being lung cancer cells App 20030147867 - Fakhrai, Habib	2003-08-07
Lymphokine gene therapy of cancer Grant 5,681,562 - Sobol , et al. October 28, 1	1997-10-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.